Market Cap 12.48M
Revenue (ttm) 17.93M
Net Income (ttm) -11.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -63.19%
Debt to Equity Ratio 0.30
Volume 76,800
Avg Vol 178,886
Day's Range N/A - N/A
Shares Out 29.02M
Stochastic %K 92%
Beta 1.33
Analysts Strong Sell
Price Target $5.00

Latest News on EKSO

Ekso Bionics Announces Third Quarter 2024 Financial Results

Oct 28, 2024, 4:05 PM EDT - 6 months ago

Ekso Bionics Announces Third Quarter 2024 Financial Results


Ekso Bionics Announces First Quarter 2024 Financial Results

Apr 29, 2024, 4:05 PM EDT - 1 year ago

Ekso Bionics Announces First Quarter 2024 Financial Results


Ekso Bionics Reports Record Annual Revenue of $18.3 Million

Mar 4, 2024, 4:05 PM EST - 1 year ago

Ekso Bionics Reports Record Annual Revenue of $18.3 Million


Ekso Bionics Launches GaitCoach Software for EksoNR

Jan 8, 2024, 4:05 PM EST - 1 year ago

Ekso Bionics Launches GaitCoach Software for EksoNR


Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%

Oct 26, 2023, 4:05 PM EDT - 1 year ago

Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%


Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

Mar 28, 2023, 4:26 PM EDT - 2 years ago

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results


Ekso Bionics Reports Third Quarter 2022 Results

Nov 3, 2022, 4:05 PM EDT - 2 years ago

Ekso Bionics Reports Third Quarter 2022 Results


Ekso Bionics: Fragile Opportunity

Aug 24, 2022, 4:34 AM EDT - 2 years ago

Ekso Bionics: Fragile Opportunity


Ekso Bionics Reports Second Quarter 2022 Results

Jul 28, 2022, 4:05 PM EDT - 2 years ago

Ekso Bionics Reports Second Quarter 2022 Results